HYFRESH EYE DROPS 10ML

Indications

Approved Uses

Symptomatic relief of dry eye (ocular surface dryness/irritation/burning/foreign-body sensation) and lubrication of the ocular surface (artificial tears).

Off-Label Uses

Adjunctive lubrication for ocular surface disease (e.g., Sjögren-related dry eye) and post-operative/post-procedure ocular surface support (as supportive care).

Dosage & Administration

Dosing by Condition

Dry eye: Instill 1 drop in the affected eye(s) 3-4 times daily or as needed; may be used more frequently based on symptoms. If used with contact lenses, follow lens instructions and avoid instilling while lenses are in unless the product labeling permits; if used, apply before insertion and after removal.

Children's Dosage

No specific pediatric dosing established; use under medical supervision in children

Dose Adjustment Notes

No dose adjustment is required in renal or hepatic impairment (minimal systemic absorption with ophthalmic use).

Side Effects

Common Side Effects

Transient blurred vision after instillation, mild eye irritation/stinging/burning, and occasional redness or discomfort.

Side Effect Frequency

Common: transient blurred vision immediately after instillation; mild stinging/burning/irritation. Uncommon: ocular redness, itching, eyelid irritation/watering. Rare: hypersensitivity reactions.

Safety & Warnings

Contraindications

Hypersensitivity to hyaluronic acid (sodium hyaluronate) or any excipients in the formulation.

Warnings & Precautions

For ophthalmic use only; avoid contaminating the dropper tip; stop and seek medical advice if pain, vision changes, or persistent/worsening irritation occur; do not use if solution is cloudy/discolored; if using contact lenses, remove before instillation and reinsert after ~15 minutes unless the product is explicitly labeled contact-lens compatible/preservative-free; follow in-use discard period per product labeling.

Age Restriction

No specific age restriction in general; for children (especially infants), use on a clinician’s advice/supervision.

Driving Warning

Safe

Drug Interactions

Drug Interactions

No clinically significant systemic drug interactions expected; if using other ophthalmic products, separate administrations by at least 5-10 minutes (apply gels/ointments last).

Interaction Severity

MINOR: Other ophthalmic products may dilute/wash out the drop if used together-separate administration by at least 5-10 minutes (ointments/gels last).

Food Interaction

No restriction

Alcohol Interaction

Safe

Special Populations

Children

No specific pediatric dosing established; use under medical supervision in children

Elderly

Standard adult dosing; no adjustment required

Kidney Impairment

No adjustment needed

Liver Impairment

No adjustment needed

Storage & Patient Advice

Stopping the Medicine

Safe to stop anytime; no tapering required

Pharmacology

Mechanism of Action

Hyaluronic acid is a viscoelastic, water-binding polymer that hydrates and lubricates the ocular surface, stabilizes the tear film, reduces friction, and can support epithelial surface recovery.

Onset of Action

Immediate (within minutes).

Duration of Effect

Variable; typically provides relief for several hours (often ~1-4 hours), depending on severity and tear dynamics.

Half-Life

Not clinically applicable; no meaningful systemic half-life is defined for ophthalmic use due to negligible systemic absorption.

Bioavailability

Negligible to minimal systemic absorption (systemic bioavailability is clinically insignificant) after ophthalmic administration.

Metabolism

Primarily local degradation/clearance on the ocular surface and tear film (e.g., enzymatic breakdown by hyaluronidases) with no clinically significant systemic metabolism expected.

Excretion

Not clinically applicable; primarily local ocular-surface action with negligible systemic exposure (no meaningful systemic excretion to characterize).

Protein Binding

Not applicable/clinically relevant because systemic absorption is negligible.

Product Information

Composition per Dose

Each mL: 20 mg hyaluronic acid (sodium hyaluronate) in ophthalmic solution

Generic Availability

Yes

OTC Alternatives

Other OTC artificial tears such as carboxymethylcellulose (CMC), hypromellose, polyvinyl alcohol, polyethylene glycol/propylene glycol, glycerin; thicker options include carbomer gels or petrolatum/mineral oil ointments (night use).

Target Organ

Eye

Legal Disclaimer - Al Mujtama Pharmacy The product information provided is derived from verified pharmaceutical references and is intended for general health education only. It is not a substitute for professional medical advice, diagnosis, or treatment. Al Mujtama Pharmacy assumes no legal or medical liability for: Any therapeutic decision made based on the information displayed without consulting a licensed physician or pharmacist Any discrepancy between the information provided and the product's package insert or SFDA guidelines Any misuse of medication resulting from personal interpretation of the content displayed Important notice: Drug formulations and instructions may vary between production batches. Always rely on the leaflet included inside the product packaging you have, and consult your pharmacist or physician before starting, adjusting, or discontinuing any medication. By using this content, you acknowledge that you have read this disclaimer and agree that Al Mujtama Pharmacy bears no liability arising from reliance on this information as a substitute for direct medical consultation. Your health is a trust - always consult your doctor first.